Argun-Kurum G, Kaya-Dagistanli F, Ozturk M
Intravenous infusion of up to 20 mg of BPC-157 in 2 healthy adults showed no adverse effects and was well-tolerated. Lee & Burgess, Alternative Therapies in Health and Medicine, 2025 Limitations : Only 2 participants Very short observation period No long-term follow-up No efficacy endpoints What These Studies Tell UsAnd What They Dont What We Can Reasonably Conclude Short-term tolerance appears acceptable : Across all three studies (roughly 30 participants total), no adverse events were reported
(2) h tr ti to cc enzyme chng oxy ho nh superoxide dismutase
Timing your supplements can make a big difference if you are trying to optimize your performance, aesthetics, and recovery
34 In a similarly sized double-blind, placebo-controlled study of intravenous ketamine (0.2 mg/kg) for treatment of migraine in the emergency department setting, however, ketamine was not superior to placebo for acute pain relief and caused adverse effects of generalized discomfort at 30 minutes and fatigue at 60 minutes, although no serious adverse events occurred
If not treated, intestinal blockages could cause death of the surrounding intestinal tissue and infection of the abdominal cavity (peritonitis)
